These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4043532)

  • 1. Cell bank characterization for recombinant DNA mammalian cell lines.
    Lubiniecki AS; May LH
    Dev Biol Stand; 1985; 60():141-6. PubMed ID: 4043532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral aspects of the characterisation of avian and mammalian cell substrates.
    Robertson JS
    Dev Biol (Basel); 2001; 106():417-22; discussion 422-4, 465-75. PubMed ID: 11761257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologicals production by recombinant DNA technology in Cuba.
    Herrera L; Del la Fuente J; Quinones Y; Padron G; Agraz A; Vega J; Perez L; Silva A; Santizo C; Alvarez R
    Dev Biol Stand; 1989; 70():257-69. PubMed ID: 2503409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of retroviruses in biologicals manufactured for human use.
    Hilfenhaus J; Gregersen JP; Müller H; Nowak T; Pranter W
    Dev Biol Stand; 1991; 75():159-69. PubMed ID: 1794617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and molecular characterization of an endogenous retrovirus present in CHO/HBs-A Chinese hamster cell line.
    Hojman F; Emanoil-Raivier R; Lesser J; Périès J
    Dev Biol Stand; 1989; 70():195-202. PubMed ID: 2668072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical assay issues with the PERT/PBRT assay: a highly sensitive reverse transcriptase assay.
    Chang A; Dusing S
    Dev Biol (Basel); 2006; 123():91-7; discussion 119-32. PubMed ID: 16566438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety issues related to the use of recombinant DNA-derived cell culture products. I. Cellular components.
    Palladino MA; Levinson AD; Svedersky LP; Obijeski JF
    Dev Biol Stand; 1987; 66():13-22. PubMed ID: 3582742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of biotechnological products: analysis of the expression construct in cell lines used for production of r-DNA derived protein products. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():205-8. PubMed ID: 9737397
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of biological products prepared from mammalian cell culture. In-process testing for viral agents.
    Dev Biol Stand; 1998; 93():130-1. PubMed ID: 9737389
    [No Abstract]   [Full Text] [Related]  

  • 11. Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization--a case study.
    Chen D; Nims R; Dusing S; Miller P; Luo W; Quertinmont M; Parekh B; Poorbaugh J; Boose JA; Atkinson EM
    Biologicals; 2008 Nov; 36(6):393-402. PubMed ID: 18757212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human retroviruses and herpesviruses: problems and solutions in safety testing of biologicals.
    Onions D; Lees G
    Dev Biol Stand; 1991; 75():145-58. PubMed ID: 1794616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to the issues: detection of retroviruses and associated risks.
    Marcus-Sekura CJ
    Dev Biol Stand; 1992; 76():137-40. PubMed ID: 1478334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience in cell line testing.
    Moore WA
    Dev Biol Stand; 1992; 76():51-6. PubMed ID: 1478356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a high-affinity chimaeric antibody against hepatitis B surface antigen.
    Bose B; Khanna N; Acharya SK; Sinha S
    Biotechnol Appl Biochem; 2006 Feb; 43(Pt 2):93-101. PubMed ID: 16253117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goat serum: an alternative to fetal bovine serum in biomedical research.
    Paranjape S
    Indian J Exp Biol; 2004 Jan; 42(1):26-35. PubMed ID: 15274477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal characterization of MRC-5 cell banks utilizing G-banding technique.
    Rosolowsky M; McKee R; Nichols W; Garfinkle B
    Dev Biol Stand; 1998; 93():109-17. PubMed ID: 9737385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
    Printz M; Reynolds J; Mento SJ; Jolly D; Kowal K; Sajjadi N
    Gene Ther; 1995 Mar; 2(2):143-50. PubMed ID: 7719931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
    Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.